10/2/2007

The U.S. Supreme Court has rejected Pfizer's request to overturn an appeals court ruling that allows Canadian drugmaker Apotex to sell generic versions of its hypertension drug, Norvasc. Pfizer's patent for the drug expired last week.

Related Summaries